Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease

被引:0
|
作者
Prasada Chowdari Gurram
Sairaj Satarker
Ajmal Nassar
Jayesh Mudgal
Madhavan Nampoothiri
机构
[1] Manipal Academy of Higher Education,Department of Pharmacology, Manipal College of Pharmaceutical Sciences
来源
Chemical Papers | 2023年 / 77卷
关键词
IKKB; Apomorphine; Rotigotine; Dopamine agonists; Neuroinflammation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1971 / 1988
页数:17
相关论文
共 50 条
  • [11] Drug repurposing for Alzheimer's disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors
    Kumar, Navneet
    Gahlawat, Anuj
    Kumar, Rajaram Naresh
    Singh, Yash Pal
    Modi, Gyan
    Garg, Prabha
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 2878 - 2892
  • [12] Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
    Xu, Chenshu
    Zou, Haoman
    Yu, Xi
    Xie, Yazhou
    Cai, Jiaxin
    Shang, Qi
    Ouyang, Na
    Wang, Yinan
    Xu, Pan
    He, Zhendan
    Wu, Haiqiang
    CHEMISTRYOPEN, 2021, 10 (09): : 877 - 881
  • [13] Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening
    Juarez-Saldivar, Alfredo
    Gomez-Escobedo, Rogelio
    Corral-Ruiz, Gerardo
    Chacon-Vargas, Karla Fabiola
    Horta-Montano, Vanessa
    Sanchez-Torres, Luvia
    Vazquez-Jimenez, Lenci k.
    Nogueda-Torres, Benjamin
    Rivera, Gildardo
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (02)
  • [14] Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4
    Wakchaure, Padmaja
    Velayutham, Ravichandiran
    Roy, Kuldeep K.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (12): : 3048 - 3057
  • [15] Structure-based virtual screening, molecular docking, and molecular dynamics simulation approaches for identification of new potential inhibitors of class a β-lactamase enzymes
    Dehkordi, Maryam Khademi
    Hoveida, Laleh
    Fani, Najmeh
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (11): : 5631 - 5641
  • [16] Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs
    Ezzemani, Wahiba
    Altawalah, Haya
    Windisch, Marc
    Ouladlahsen, Ahd
    Saile, Rachid
    Kettani, Anass
    Ezzikouri, Sayeh
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (15): : 8073 - 8088
  • [17] Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents
    Gomez-Escobedo, Rogelio
    Mendez-alvarez, Domingo
    Vazquez, Citlali
    Saavedra, Emma
    Vazquez, Karina
    Alcantara-Farfan, Veronica
    Cordero-Martinez, Joaquin
    Gonzalez-Gonzalez, Alonzo
    Rivera, Gildardo
    Nogueda-Torres, Benjamin
    MOLECULES, 2024, 29 (16):
  • [18] Prospect of Anterior Gradient 2 homodimer inhibition via repurposing FDA-approved drugs using structure-based virtual screening
    Ullah, Shafi
    Khan, Shafi Ullah
    Khan, Abbas
    Junaid, Muhammad
    Rafiq, Humaira
    Htar, Thet Thet
    Zhao, Yaxue
    Shah, Syed Adnan Ali
    Wadood, Abdul
    MOLECULAR DIVERSITY, 2022, 26 (03) : 1399 - 1409
  • [19] Phytocompounds of Senecio candicans as potential acetylcholinesterase inhibitors targeting Alzheimer's disease: A structure-based virtual screening and molecular dynamics simulation study
    Periyasamy, Tamilarasi Sambu
    Kasivishwanathan, Ajay
    Roy, Gilbert
    Sekar, Nishu
    Lakshmanan, Hariprasath
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2025, 117
  • [20] Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer's disease
    Devi, Bharti
    Jangid, Kailash
    Kumar, Naveen
    Kumar, Vinay
    Kumar, Vinod
    MOLECULAR DIVERSITY, 2024, 28 (06) : 4361 - 4380